Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSeeing Machines Regulatory News (SEE)

Share Price Information for Seeing Machines (SEE)

Share Price is delayed by 15 minutes
Get Live Data
4.40    0.00 (0.00%)
Bid:
4.40
Ask:
4.525
Spread: 0.125 (2.841%)
Market Cap: £211.18m
SEE Live PriceLast checked at - London Stock Exchange

Intraday Seeing Machines Share Chart

Appointment of CFO

18 Jun 2013 07:00

RNS Number : 2274H
Seeing Machines Limited
18 June 2013
 

Seeing Machines Limited

("Seeing Machines" or "the Company")

Seeing Machines Appoints New CFO

Canberra, Australia, 17th June 2013 - Seeing Machines (AIM: SEE), today announces the appointment of James Walker to the position of CFO with immediate effect. 

James is a Fellow of the Institute of Chartered Accountants of Australia and has a Bachelor of Commerce degree from the University of New South Wales.

Most recently James was CFO and COO and, for 7 months, acting CEO, of Optalert Limited, a company specialising in driver fatigue monitoring technology.

He brings extensive experience as a CFO across a range of international high growth businesses in the mining services, hospitality, biotechnology and technology commercialisation sectors.

James brings particular experience in M&A transactions, IPO listing, Australian Stock Exchange (ASX) compliance, corporate governance, raising capital and institution and shareholder communications.

Ken Kroeger, CEO of Seeing Machines, commented: "We are delighted to have been able to attract a CFO of James's experience and track record and it is a bonus that he brings significant sector experience to the company. He will be an important addition to our senior team as we steer the Company through the next few years of significant growth."

About Seeing Machines

Seeing Machines, (AIM: SEE), is an AIM-listed technology company that specialises in visual computing systems that track faces, eye and facial features in real time. Its software and engineering services are used in products and applications that range from devices that detect eye disease to prevent loss of sight, to those that improve driver safety and save lives. Seeing Machines technology is used worldwide across the automotive, mining, gaming, transport and aviation industries; as well as many of the leading academic research groups, transportation authorities, and Defence Departments. Seeing Machines is based in Canberra, Australia, and Tucson, Arizona and counts Freeport McMoRan, BHP Billiton, Newmont, Cloud Peak Energy, Toll Mining Services and Teck Resources among its mining customers.

For further information please contact:

 

 

Ken Kroeger, CEO

Seeing Machines Limited

ken.kroeger@seeingmachines.com

Tel: +61 2 6103 4700

Terry Winters, Chairman

Seeing Machines Limited

Terry.winters@seeingmachines.com

Tel: +61 411 411 111

Ed Frisby / Ben Thompson (corporate finance)

Simon Starr (corporate broking)

finnCap

Tel: +44 20 7220 0500

James Kennedy

AxiCom

James.kennedy@axicom.com

Tel: +44 20 8392 4091

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRAMMGMVKNVGFZM
Date   Source Headline
9th Jun 20217:00 amRNSSEE and CAE to deliver Crew Training System
7th Jun 20217:00 amRNS21st Century Smart Cars Act Legislation
28th Apr 20217:09 amRNSDMS central to improved safety on US roads
26th Apr 20217:00 amRNSDMS award brings OEM customer count to seven
31st Mar 20217:00 amRNSHalf-year results and financial report
22nd Mar 20217:00 amRNSIssue of shares and total voting rights
19th Mar 20217:16 amRNSNotice of Results and Investor Presentation
8th Feb 20217:00 amRNSSEE DMS Available in 2021 Cadillac Escalade
3rd Feb 20217:30 amRNSHolding(s) in Company
1st Feb 20217:00 amRNSHalf year trading update
27th Jan 20217:00 amRNSQualcomm and Seeing Machines collaboration
13th Jan 20214:41 pmRNSSecond Price Monitoring Extn
13th Jan 20214:35 pmRNSPrice Monitoring Extension
13th Jan 20218:48 amRNSHolding(s) in Company
6th Jan 20217:00 amRNSLicense Agreement with OmniVision Technologies
22nd Dec 20207:00 amRNSFleet Update
30th Nov 20209:19 amRNS2020 AGM Results and Board Changes
25th Nov 202011:50 amRNSDirector/PDMR Shareholding
23rd Nov 202010:00 amRNSShare Transfer & Issue of Performance Rights
5th Nov 20208:02 amRNSNotice of AGM
2nd Nov 202011:43 amRNSHolding(s) in Company
2nd Nov 20207:00 amRNSYear End Results
30th Oct 20209:19 amRNSHolding(s) in Company
30th Oct 20207:00 amRNSWebcast Presentation - Year End Results
29th Oct 202011:39 amRNSHolding(s) in Company
29th Oct 20207:00 amRNSHolding(s) in Company
23rd Oct 20207:00 amRNSIssue of Shares & Total Voting Rights
21st Oct 20207:00 amRNSSEE signs MOU with L3Harris Technologies
12th Oct 20207:00 amRNSSEE extends leading DMS to Occupant Monitoring
16th Sep 20207:15 amRNS5 billion kilometres of Guardian driving data
14th Sep 20207:00 amRNSLaunch of DMS Kit on Qualcomm Snapdragon Platform
8th Sep 20209:05 amRNSSecond Price Monitoring Extn
8th Sep 20209:00 amRNSPrice Monitoring Extension
8th Sep 20207:00 amRNSSEE signs MOU with leading Semiconductor Company
2nd Sep 20209:00 amRNSNext Gen Embedded Product Strategy for Auto DMS
14th Aug 202010:55 amRNSShare purchase by PCA of non-executive director
3rd Aug 20207:00 amRNSFY20 Trading Update
7th Jul 20207:00 amRNSUS set to mandate DMS from 2024
19th May 20207:00 amRNSBusiness restructure and Covid measures
14th May 20207:00 amRNSBoard Changes
6th May 202011:05 amRNSSecond Price Monitoring Extn
6th May 202011:00 amRNSPrice Monitoring Extension
5th May 20204:41 pmRNSSecond Price Monitoring Extn
5th May 20204:35 pmRNSPrice Monitoring Extension
14th Apr 20201:53 pmRNSHolding(s) in Company
9th Apr 20207:00 amRNSDirector/PDMR Shareholding
6th Apr 20204:40 pmRNSSecond Price Monitoring Extn
6th Apr 20204:35 pmRNSPrice Monitoring Extension
2nd Apr 20202:06 pmRNSSecond Price Monitoring Extn
2nd Apr 20202:00 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.